GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » YoY EBITDA Growth

Elixxer (Elixxer) YoY EBITDA Growth : -146.00% (As of Sep. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Elixxer YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Elixxer's YoY EBITDA Growth for the quarter that ended in Sep. 2023 was -146.00%.

Elixxer's EBITDA per Share for the three months ended in Sep. 2023 was $-0.02.

Elixxer YoY EBITDA Growth Historical Data

The historical data trend for Elixxer's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixxer YoY EBITDA Growth Chart

Elixxer Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Sep17 Sep18 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -141.19 -107.02 71.00 83.91 -355.36

Elixxer Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.49 -162.30 89.74 94.51 -146.00

Elixxer YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Elixxer's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(-0.765--0.168)/ | -0.168 |
=-355.36 %

Elixxer's YoY EBITDA Growth for the quarter that ended in Sep. 2023 is calculated as:

YoY EBITDA Growth (Q: Sep. 2023 )
=(EBITDA per Share (Q: Sep. 2023 )-EBITDA per Share (Q: Sep. 2022 )) / | EBITDA per Share (Q: Sep. 2022 )) |
=(-0.023-0.05)/ | 0.05 |
=-146.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elixxer YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Elixxer's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixxer (Elixxer) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixxer Ltd (OTCPK:ELIXF) » Definitions » YoY EBITDA Growth
Comparable Companies
BLMS NEPTF THCT HCANF INLB BGPPF DVLP STMH BBBT DMKPQ XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
1100 Boulevard Rene- Levesque Ouest, Suite 700, Montreal, QC, CAN, H5B 4N4
Website
https://www.elixxer.com
Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.